To Evaluate the Comparative Pharmacokinetics of Orally Administered EQ143 in Different Racial and Ethnic Populations

Clinical trial NCT04969965 · COMPLETED

Trial details

NCT number: NCT04969965
Sponsor: EQRx, Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

NSCLC Healthy Volunteers Pharmacokinetics

Start date: 2021-06-21
Primary completion: 2021-10-07
Enrollment: 45

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.